Anheuser-Busch InBev SA/NV (NYSE:BUD – Get Free Report) had its price target lowered by investment analysts at Morgan Stanley from $70.00 to $68.50 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has an “overweight” rating on the consumer goods maker’s stock. Morgan Stanley’s price target would suggest a potential upside of 17.11% from the company’s current price.
Other research analysts also recently issued reports about the stock. UBS Group raised shares of Anheuser-Busch InBev SA/NV from a “neutral” rating to a “buy” rating in a research report on Monday, June 24th. TD Cowen cut their price target on Anheuser-Busch InBev SA/NV from $67.00 to $65.00 and set an “outperform” rating for the company in a research note on Tuesday, March 5th. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, Anheuser-Busch InBev SA/NV has an average rating of “Moderate Buy” and an average price target of $72.13.
Check Out Our Latest Analysis on BUD
Anheuser-Busch InBev SA/NV Stock Up 0.2 %
Anheuser-Busch InBev SA/NV (NYSE:BUD – Get Free Report) last released its quarterly earnings data on Wednesday, May 8th. The consumer goods maker reported $0.75 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.06. The business had revenue of $14.55 billion for the quarter, compared to the consensus estimate of $14.43 billion. Anheuser-Busch InBev SA/NV had a return on equity of 14.01% and a net margin of 8.03%. The business’s revenue for the quarter was up 2.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.65 EPS. Equities research analysts anticipate that Anheuser-Busch InBev SA/NV will post 3.42 earnings per share for the current year.
Institutional Investors Weigh In On Anheuser-Busch InBev SA/NV
Several institutional investors have recently made changes to their positions in the stock. DAVENPORT & Co LLC grew its position in Anheuser-Busch InBev SA/NV by 25.9% during the fourth quarter. DAVENPORT & Co LLC now owns 1,507,181 shares of the consumer goods maker’s stock worth $97,415,000 after buying an additional 309,977 shares during the period. Capital International Investors grew its position in shares of Anheuser-Busch InBev SA/NV by 0.9% in the fourth quarter. Capital International Investors now owns 2,124,860 shares of the consumer goods maker’s stock valued at $137,447,000 after purchasing an additional 18,280 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Anheuser-Busch InBev SA/NV by 232.4% during the 4th quarter. SG Americas Securities LLC now owns 25,052 shares of the consumer goods maker’s stock worth $1,619,000 after purchasing an additional 17,516 shares during the last quarter. Simplicity Wealth LLC purchased a new position in Anheuser-Busch InBev SA/NV during the first quarter worth $1,604,000. Finally, Perpetual Ltd boosted its stake in shares of Anheuser-Busch InBev SA/NV by 13.7% during the first quarter. Perpetual Ltd now owns 127,155 shares of the consumer goods maker’s stock valued at $7,736,000 after acquiring an additional 15,364 shares during the last quarter. 5.53% of the stock is currently owned by hedge funds and other institutional investors.
Anheuser-Busch InBev SA/NV Company Profile
Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands.
Featured Articles
- Five stocks we like better than Anheuser-Busch InBev SA/NV
- Retail Stocks Investing, Explained
- RXO Shares Surge Following New Acquisition Deal
- Dividend Capture Strategy: What You Need to Know
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Anheuser-Busch InBev SA/NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anheuser-Busch InBev SA/NV and related companies with MarketBeat.com's FREE daily email newsletter.